Ousia Pharma
Copenhagen, Denmark · $7.2M raised
- Headquarters
- Copenhagen
- Employees
- 1–10
- Business Model
- B2B
- Website
- ousiapharma.com
- Total Funding
- $7.2M
- Last Round
- $7.2M SeedMay 2025
- Rounds
- 1
About
Ousia Pharma ApS is a biotech spinout from the University of Copenhagen focused on novel peptide-drug conjugates for metabolic diseases including obesity. The company secured seed financing led by Omega Funds.
Summary
Ousia Pharma is a Biotech company based in Copenhagen, Denmark. It has raised $7.2M in total across 1 round, most recently a $7.2M Seed round in May 2025. Investors include Omega Funds.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...